Evidence map›Paper›PMID 31475166›Full record

ArticleAnnals of translational medicine2019

Genetic variants and clinical significance of pediatric acute lymphoblastic leukemia.

Hong-Hong Zhang, Hong-Sheng Wang, Xiao-Wen Qian, Cui-Qing Fan, Jun Li, Hui Miao, Xiao-Hua Zhu, Yi Yu, Jian-Hua Meng, Ping Cao and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012-2016.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  5. Special Issue "Personal Therapy for Blood Disorders".Journal of personalized medicine · 2023
    Article
  6. Identification ofInternational journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Frontiers in oncology · 2021
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Hong-Hong ZhangDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Hong-Sheng WangDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Xiao-Wen QianDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Cui-Qing FanDepartment of Pediatrics, Children's Hospital of Fudan University, Shanghai 201102, China.
Jun LiDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Hui MiaoDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Xiao-Hua ZhuDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Yi YuDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Jian-Hua MengDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Ping CaoDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Jun LeDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Jun-Ye JiangDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Wen-Jing JiangDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Ping WangDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Xiao-Wen ZhaiDepartment of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai 201102, China.
Children's Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute lymphoblastic leukemia (ALL), the most common childhood malignancy, is characterized by molecular aberrations. Recently, genetic profiling has been fully investigated on ALL; however, the interaction between its genetic alterations and clinical features is still unclear. Therefore, we investigated the effects of genetic variants on ALL phenotypes and clinical outcomes.

methodsTargeted exome sequencing technology was used to detect molecular profiling of 140 Chinese pediatric patients with ALL. Correlation of genetic features and clinical outcomes was analyzed.

resultsT-cell ALL (T-ALL) patients had higher initial white blood cell (WBC) count (34.8×10

conclusions

Indexed as

Acute lymphoblastic leukemia (ALL)clinical significancegenetic variantsnext-generation sequencing (NGS)pediatric

Identifiers

PMID31475166
PMCPMC6694231
OpenAlexW2947734730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.